Fios Genomics

Executive Summary

Fios Genomics is a UK-based bioinformatics services company founded in 2008 that specializes in the biological interpretation of complex multi-omics data. Serving pharmaceutical, biotechnology, and academic clients, the company transforms raw data from genomics, transcriptomics, proteomics, metabolomics, and epigenetics into actionable insights to accelerate R&D. With over a decade of experience, Fios has built a reputation for reliable, high-quality analysis services that help clients reduce time-to-insight and improve decision-making in drug discovery and development. The company operates as a private, pre-clinical stage entity headquartered in Edinburgh, Scotland, and continues to expand its service offerings to meet growing demand for integrated multi-omics solutions.

Upcoming Catalysts (preview)

• Q3 2026Partnership with Major Pharma for Multi-Omics Integration70% success
• Q4 2026Launch of AI-Driven Data Analysis Platform65% success
• Q2 2027Expansion into US Market via New Office or Collaboration50% success